✨ Free AI Report
Cerus Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Cerus Corporation
Research Preview

Cerus Corporation: Business Overview, Financials & Competitive Analysis

Cerus Corporation operates as a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is a proprietary technology designed...

Analyst-debate audio for Cerus Corporation

AskCyborg analysts argue the bull and bear cases for Cerus Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Cerus Corporation OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Specialized blood safety company with FDA/CE approval, expanding product portfolio, but valuation and execution risks warrant...

Read the full analyst-debate transcript →
Industry Medical Devices - Blood Safety & Pathogen Reduction Technologies
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Cerus Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Cerus Corporation Overview

Pro stress-test →

Cerus Corporation operates as a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is a proprietary technology designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Strategic Profile

Pro stress-test →

The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The company operates on a B2B model targeting blood centers, hospitals, and healthcare providers, generating revenue through the sale of INTERCEPT Blood System products, service contracts, and licensing agreements.

Competitive Landscape

Pro stress-test →

Haemonetics Corporation competes with Cerus in certain blood management product categories. Macopharma, a European company, provides blood processing and pathogen inactivation solutions. Several startups are developing innovative blood safety technologies, posing potential threat to Cerus's market share.

Industry Context

Cerus Corporation operates in Medical Devices - Blood Safety & Pathogen Reduction Technologies.

Key facts

Founded: 1991 · Headquarters: Concord, California, United States · Employees: 281 · Revenue: $201.3M · Market cap: $311.2M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Cerus Corporation.

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Cerus Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Blood Management SolutionsCompetes in blood management products→Pathogen Inactivation SolutionsEuropean blood processing and pathogen inactivation provider→Emerging Blood Safety TechnologiesDeveloping innovative blood safety alternatives→

Compare Cerus Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Cerus Corporation operates in Medical Devices - Blood Safety & Pathogen Reduction Technologies. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Blood Safety & Pathogen Reduction Technologies research →
NEW · MCP server

Ask your AI assistant about Cerus Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Cerus Corporation and its top competitor on Cyborg Score”
“What did Cerus Corporation do this quarter?”
“Is Cerus Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Cerus Corporation do?+
Cerus Corporation operates as a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is a proprietary technology designed...
What is Cerus Corporation's Cyborg Score?+
Cerus Corporation has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Cerus Corporation's main competitors?+
Named competitors include Blood Management Solutions, Pathogen Inactivation Solutions, Emerging Blood Safety Technologies. The full competitive landscape is in the AskCyborg report.
How can I get the full Cerus Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Cerus Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Cerus Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.